The prevalence and clinical profile of adrenocortical deficiency among HIV infected persons in Northern Nigeria by Akase, Iorhen E et al.
The prevalence and clinical profile of  adrenocortical deficiency among HIV 
infected persons in Northern Nigeria
Iorhen E Akase1, Abdurazaq G Habib2, Adamu G Bakari3, Hamza Muhammad2, Ibrahim D Gezawa4
1. Infectious Disease unit, Lagos University teaching Hospital, Lagos.
2. Infectious Disease unit, Aminu Kano Teaching Hospital, Kano.
3. Endocrinology Unit, Ahmadu Bello University teaching Hospital, Zaria.
4. Endocrinology Unit, Aminu Kano Teaching Hospital, Kano.
Emails: 
A.G. Habib:  Email = abdulrazaq_habib@yahoo.co.uk; A.G. Bakari:  Email = abgirei@yahoo.com; M. Hamza:    Email 
= drhamza1020@ymail.com; I.D. Gezawa: Email = gezawa01@yahoo.com
Abstract
Background: Infection with the human immune deficiency virus (HIV) is still a prevalent problem in Africa.
Objectives: The aim of  this study was to determine the prevalence of  hypocortisolism among patients with HIV and their 
clinical profile at Aminu Kano Teaching Hospital (AKTH), Kano, Nigeria.
Method: Three hundred and fifty adult patients with HIV infection were recruited from the HIV clinic of  AKTH, Kano. Blood 
samples for serum electrolytes, and cortisol both before and after the short Synacthen test were taken for estimation. Data were 
analyzed using the SPSS version 20.0 software.
Results: One hundred and eight (30.9%) of  participants had low baseline serum cortisol levels, while 57 (16.3%) had a low se-
rum cortisol after short synacthen test. There was no significant relationship between the cortisol levels and clinical features of  
hypocortisolism, WHO clinical stage of  HIV, hypernatremia or HAART regimen. There was a negative correlation between the 
stimulated serum cortisol and duration of  diagnosis of  HIV, participants BMI and CD4 counts. 
Conclusion: The biochemical evidence of  hypocortisolism was common among patients infected with HIV,  associated with 
a longer duration of  HIV infection. However, none of  CD4 counts, clinical features or HAART regimen were associated with 
hypocortisolism.
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Introduction
Infection with the human immune deficiency virus (HIV) 
is still a prevalent problem despite significant strides in its 
control, with an estimated 36.7 million people infected 
worldwide, 69.5% of  whom are resident in sub-Saharan 
Africa.1 In Nigeria, about 3.1% of  the population are cur-
rently living with HIV infection, amounting to about 3.5 
million people.1
Adrenal gland dysfunction was one of  the earliest endo-
crine problems documented in people infected with HIV 
and presenting with AIDS, with several autopsy studies 
revealing various abnormalities of  the adrenal gland.2,3 It 
is thought that the presence of  adrenal insufficiency may 
contribute to increased morbidity in HIV patients, and 
may serve as a predictor of  poor outcomes in patients 
with HIV infection4.  Few studies have been conducted 
in Nigeria to demonstrate the burden of  hypocortisolism 
among HIV patients in Nigeria. A study by Odeniyi et al 
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among newly diagnosed HIV patients in Lagos Nigeria 
showed that 34.8% of  the tested patients had hypocor-
tisolism.5 Studies elsewhere in  Africa show that hypoad-
renalism hypocortisolism is a common problem among 
patients infected with HIV,6-7 and may contribute signifi-
cantly to both morbidity and mortality among these pa-
tients.
Given the significance of  hypocortisolism in HIV infec-
tion and the paucity of  information in Northern Nigeria, 
the aim of  this study was to evaluate adrenal function us-
ing the short Synacthen test in this group of  patients, and 
determine the prevalence of  hypocortisolism, and the 
clinical profile of  affected patients at the Aminu Kano 
Teaching Hospital (AKTH), Kano. 
Methods
This study was descriptive cross-sectional study, con-
ducted at the AKTH, Kano. The study subjects included 
three hundred and fifty (350) consecutive patients with 
HIV infection presenting at the ART clinic of  AKTH 
Kano. The estimated sample size of  348 was arrived at 
using the formula: n = Z2 pq/d2.8 The prevalence of  hy-
pocortisolism in persons with HIV infection was taken to 
be 34.8%.5 Three hundred and fifty patients (350) were 
therefore recruited for this study. Recruited patients were 
adults (≥18 years), who were confirmed to have HIV in-
fection according to the serial testing algorithm in accor-
dance with the national guidelines.
Participants were recruited from September 2015 to Jan-
uary 2016. All the recruited patients were interviewed 
for features suggestive of  hypocortisolism. They subse-
quently underwent laboratory evaluation for the detec-
tion of  hypocortisolism.
Patients presenting in addisonian crisis, those who were 
on steroids, and other drugs that could interfere with ad-
renal function (e.g. ketoconazole, phenytoin, and rifampi-
cin) were excluded from the study.
Patients’ clinical data were collected using an interview-
er administered questionnaire. Blood samples for serum 
cortisol estimation were taken at baseline and at 30 min-
utes following the administration of  1μg of  tetracosactrin 
(Synacthen). In addition, the patients had blood samples 
taken at 0 minutes (baseline) for serum urea, electrolytes 
and creatinine.
After explaining the procedure to the patient, 1μg of  Syn-
acthen was prepared by adding 250μg of  tetracosactrin 
(Synacthen) (1mL) into 499 mL of  normal saline and 
mixing the solution thoroughly. Each 2 mL of  the diluted 
solution contained 1 μg tetracosactrin (Synacthen). The 
solution thus prepared was sealed after each usage and 
stored in a refrigerator at 4-80C.
The short Synacthen test was conducted in the morning 
between 8:00 AM and 9:00AM. All the recruited partic-
ipants had serum measurement both at baseline and 30 
minutes after Synacthen administration. After securing 
a venous access, the site was observed for the presence 
of  hematoma or bleeding. One mL of  normal saline was 
then injected to ensure patency of  the vein, and 3 mL of  
blood was taken at 0 minutes, following which, 1 μg of  
Synacthen was injected intravenously. Another 3 mL of  
blood was drawn after 30 minutes. All the blood samples 
were kept on ice slabs and transported to the laboratory 
using ice packs for separation and storage of  the serum 
at -200C until assayed. Estimation of  serum cortisol was 
done after pooling of  samples. The Calbiotech® Cortisol 
ELISA kit (Calbiotech Inc., Spring Valley, CA, USA) was 
used for the serum cortisol assay. Hypocortisolism was 
defined as early morning basal serum cortisol less than 
145 μg/L (400 nmol/L) and a 30 minute post-ACTH 
(stimulated) serum cortisol level of  less than 180 μg/L 
(500 nmol/L).
All data were analyzed using Statistical Package for Social 
Sciences (SPSS), version 20.0, Chicago, IL USA. Partici-
pants’ serum cortisol was presented as median with range 
while other quantitative variables like age, BMI, blood 
pressure, serum urea and electrolytes were presented as 
means and standard deviation. The qualitative variables 
were presented as proportions and percentages. Statistical 
test of  significance at 5% alpha level was done using the 
appropriate test statistic, and were considered significant 
for p values<0.05. The student t-test was used to compare 
the means of  quantitative variables while the Mann-Whit-
ney U test was used to compare the medians of  the stim-
ulated serum cortisol among participants with normal se-
rum cortisol and those with hypocortisolism. The χ2 test 
was used to compare proportions between two or more 
groups and to test for association between two nominal 
scale variables. The linear-by-linear association was used 
to measure the association between nominal and ordinal 
variables. Logistic regression analysis was carried out to 
determine the predictors of  hypocortisolism among the 
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participants, using clinical features, duration of  treatment, 
BMI, and serum urea and electrolytes as predictors.
The Ethical & Scientific committee of  AKTH approved 
the study. Written informed Consent was obtained from 
each participant after demonstrating a satisfactory level 
of  understanding regarding the nature and extent of  their 
involvement and had willingly agreed to participate. Con-
sent on behalf  of  very sick patients for the study was 
given by the patients’ next of  kin after they demonstrat-
ed a clear understanding of  the nature and extent of  the 
study. Information and data derived were kept confiden-
tial and treated as such by the investigators. Participants 
who were found to have low serum cortisol were referred 
and linked to the Endocrine clinic of  the Aminu Kano 
Teaching Hospital, Kano.
Results
The mean (SD) age of  the study participants was 39.75 ± 
9.22 years; 172 (49.1%) of  the participants were male and 
178 (50.9%) were females.
Serum cortisol
Analysis of  the baseline serum cortisol showed that 108 
(30.9%) of  the 350 study participants had serum cortisol 
levels below 145 μg/L with a median value of  75.48 μg/L 
(11.36-144.96). (Median difference = 120.78, p< 0.001, 
Mann-Whitney U test). Following the administration of  
1 μg of  ACTH, 57 (16.3%) participants had measured se-
rum cortisol values of  less than 180 μg/L with a median 
value of  118 μg/L (19.43-179.62). (Median difference = 
133.69, p<0.001, Mann-Whitney U test)
Clinical features
The commonest observed symptom among participants 
with hypocortisolism was anorexia, which was observed 
in 13 (22.8%) participants with low stimulated serum cor-
tisol, followed closely by weight loss, fever, lethargy and 
hyperpigmentation. Abdominal pain occurred in only one 
participant with low stimulated serum cortisol (1.75%). 
None of  the participants with low levels of  stimulated 
serum cortisol reported symptoms of  diarrhea. The most 
commonly documented examination finding among par-
ticipants with low stimulated serum cortisol was pallor 
detected in 13 (22.8%) of  the respondents. None of  the 
participants with low stimulated serum cortisol levels was 
noted to have skin hyperpigmentation.
See Table 1.
Table 1 showing some of the symptoms of the participants  
 
Clinical feature Hypoadrenalism 
(n = 57) 
Normal  
(n = 273) 
p value 
Anorexia 13 (22.8%) 57 (19.5%) 0.56 
Weight loss 10 (17.5%) 54 (18.4%) 0.87 
Fever 9 (15.8%) 44 (15%) 0.88 
Lethargy  9 (15.8%) 51 (14.6%) 0.77 
Headache 6 (10.5%) 10 (3.4%) 0.02 
Skin rashes 5 (8.7%) 29 (9.9%) 0.79 
Abdominal pains 1 (1.75%) 9 (3%) 0.59 
Diarhhoea 0 8 (2.7%) 0.21 
Pallor 13 (22.8%) 47 (16%) 0.22 
Oral thrush 2 (3.5%) 6 (2%) 0.49 
Dyspigmentation 0 4 (1.4%) 0.38 
 
Duration from diagnosis of  HIV
The highest proportion of  the participants with low stim-
ulated serum cortisol was found among those who had 
been on treatment for 6-10 years (20.4% [21 out of  103]). 
The participants that had hypocortisolism were noted to 
have had a longer duration of  HIV compared with those 
that had normal adrenal function (4.96 years versus 4.38 
years, mean difference = -0.583, p= 0.28).
Anthropometry and BP measurement
Participants with hypocortisolism were noted to have a 
higher BMI as shown in Table 2. (Mean difference -0.78, 
95% CI= -2.20 – 0.64, p= 0.28). 
Postural drop in systolic was observed in 8 of  57 (14.04%) 
participants with hypocortisolism compared to 10 of  293 
(3.41%) with normal function; however, only 7.56% of  
the postural drop in systolic drop was dependent on the 
adrenal status of  the participants (η2 = 0.00756).
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Table 2: Clinical signs and anthropometry of the study participants 




P value CI 
BMI (Kg/m2) Underweight 43 7 0.18  
Normal weight 145 25   
Overweight 80 17   
Obese 22 7   
Total 290 56   
     
Clinical 
signs 
Supine SBP 127.40 (27.34) 120.64 (20.74) 0.06 1.31 - 13.4  
Supine DBP 85.78 (16.25) 81.31 (14.81) 0.12 0.58 – 9.24 
Standing SBP 122.58 (22.43) 119.29 (21.58) 0.30 3.02 – 9.59 
Standing DBP 83.07 (15.58) 81.76 (14.97) 0.56 -1.31 – 13.42 
 Pallor 47 (16%) 13 (22.8%) 0.22  
 Oral thrush 6 (2%) 2 (3.5%) 0.49  
 Dyspigmentation 4 (1.4%) 0 0.38  
 
Serum electrolytes
Only 2 (3.5%) of  the participants with a low stimulated 
serum cortisol had elevated serum urea levels., with 12 
(21.1%) of  those with low stimulated serum cortisol not-
ed to have hyponatraemia.
None of  the participants with low stimulated serum cor-
tisol had hyperkalaemia, with 12 (21%) of  the partici-
pants with low stimulated serum cortisol found to have 
hypokalaemia., as shown in Table 3 below.
A logistic regression analysis was conducted to predict 
the occurrence of  hypocortisolism using duration of  
treatment, BMI, and serum urea and electrolytes as pre-
dictors. A test of  the full model against a constant only 
model was not statistically significant, indicating that the 
predictors as a set did not reliably distinguish between the 
presence of  hypocortisolism and normal adrenal func-
tion (χ2 = 17.99, p= 0.59, df  = 20). Nagelkerke’s R2 of  
0.12 indicated a weak relationship between prediction and 
grouping. Prediction success overall was 82.2% (99.1% 
for normal adrenal function and 2.1% for the occurrence 
of  hypocortisolism). The Wald criterion demonstrated 
that only serum potassium made a significant prediction 
(OR= 2.2, p= 0.04).
 Table 3: Laboratory parameters of participants 
Parameter Frequency (Percentage) P value 
Normal Cortisol Hypoadrenalism  
Baseline Cortisol (μg/L) 196.26 (151-525 ) 75.48 (11.36-144.96) <0.001 
Stimulated Cortisol (μg/L) 251.69 (181.91-865.23) 118 (19.43-179.62) <0.001 
Urea (mmol/L) 4.23 ± 1.9  3.90 ± 1.3  0.21 
Sodium (mmol/L) 137.53 ± 6.3  136.81 ± 5.7  0.42 
Potassium (mmol/L) 3.84 ± 0.44  3.87 ± 0.5  0.64 
Chloride (mmol/L) 99.77 ± 6.05  99.81 ± 5.3  0.78 
Bicarbonate (mmol/L) 21.68 ± 2.4  22.37 ± 2.2  0.04 
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Discussion
The prevalence of  hypocortisolism using the stimulated 
serum cortisol concentration of  16.3% as observed in 
this study was lower than the 34.8% observed in Lagos 
by Odeniyi et al 5 although that study comprised only 
newly diagnosed HAART naïve patients. The prevalence 
of  30.9% using basal serum cortisol was similar to that of  
a study done in South Africa which found a prevalence 
of  27%7. The South African study however recruited pa-
tients who were taking anti-fungals and anti-convulsants 
at the time of  evaluation, both of  which are known to 
interfere with serum cortisol measurements.8,9 The prev-
alence of  16.3% using stimulated serum cortisol levels 
is similar to the 19% found by Meya et al6  in Makerere, 
although the study was conducted among patients who 
were admitted with various critical illnesses in HIV (e.g. 
Tuberculosis – pulmonary and extra-pulmonary,  crypto-
coccal meningitis, kaposi sarcoma, pneumocystis jiroveci 
pneumonia etc).
Majority of  the participants with hypocortisolism in this 
study as measured by stimulated serum cortisol had no 
symptoms traditionally thought to be suggestive of  hy-
pocortisolism. On the other hand, most of  the patients 
without  hypocortisolism had features which may be seen 
in patients with hypocortisolism. This is consistent with 
findings by other authors who have noted a poor cor-
relation between clinical features suggestive of  hypocor-
tisolism  in HIV patients with adrenal insufficiency.5, 6,10 In 
the study by Meya et al6, symptoms of  fatigue, anorexia, 
weight loss and vomiting occurred with similar frequen-
cy among those who had adrenal insufficiency and those 
with normal cortisol function.
In fact, most of  the studies quoted above found no reli-
able way of  identifying HIV patients based on symptoms, 
as patients without symptoms were found to have adrenal 
insufficiency and those with symptoms found to have a 
normal serum cortisol level at baseline and on stimula-
tion with low dose ACTH. Studies have shown however, 
that some patients with symptoms of   hypocortisolism 
whose initial serum cortisol tests are normal later develop 
impaired adrenocortical response on repeat testing with 
ACTH and overnight Metyrapone test.11,12
The significant relationship between serum potassium 
and hypocortisolism found in our study is in keeping with 
the established fact that hypocortisolism in HIV negative 
patients is associated with hyperkalaemia and hyponatrae-
mia.13,14 In the study by Odeniyi et al5, there was no rela-
tionship between serum electrolytes and the occurrence 
of  adrenal insufficiency, a finding reproduced in sever-
al studies elsewhere.6,10,11,15 Meya et al6 in Makerere also 
noted that electrolyte levels were normal in subjects with 
functional adrenal insufficiency and those with normal 
cortisol function.7 In addition, none of  hypokalaemia, 
hyponatraemia or hypoglycaemia was associated with ad-
renal insufficiency.7 In fact, it is generally agreed that the 
classical findings of  hyponatraemia and hyperkalaemia 
are seldom seen in HIV patients with hypocortisolism.16,17
The observed change in the clinical and characteristics 
among HIV patients with hypocortisolism  may be the 
result of  the changing epidemiology of  the HIV epidem-
ic. HIV detection is occurring at earlier stages than was 
obtained earlier in the epidemic. Additionally, routine 
screening and prophylactic treatment for most ois has 
led to reduced incidence of  destructive and/ or granulo-
matous lesions of  the adrenal gland. It is also worthy of  
note that patients with functional adrenocortical insuffi-
ciency are known to have a residual adrenal reserve, and 
are therefore less likely to present with the frank features 
that are seen in patients with symptomatic adrenal insuf-
ficiency.
There is much that remains unknown. There is debate as 
to whether patients with immunosuppression from HIV 
presenting with hypocortisolism will benefit from steroid 
replacement at all. Additionally, it is not yet clear the role 
of  persistent inflammation in the setting of  HIV and 
whether this eventually produces adrenal ‘exhaustion’, 
with resultant hypocortisolism among patients who have 
been diagnosed with HIV for long periods.
This study was limited by the cross-sectional design and 
the consecutive sampling. It would have been ideal to 
follow-up these participants with hypocortisolism over 
timeto establish how many eventually developed symp-
toms of  adrenal insufficiency. Additionally, we did not 
evaluate for ois and possible etiologic entities that were 
present at the time of  study.
Conclusion
Hypocortisolism detected on biochemical testing is a 
common problem among patients who are infected with 
HIV. The occurrence of   hypocortisolism among patients 
infected with HIV cannot be predicted accurately on the 
basis ofpatients’ clinical features or electrolyte abnormal-
ities. Longer duration of  HIV infection is associated with 
hypocortisolism.
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This study further stresses the need for the clinician to 
have a high index of  suspicion when dealing with patients 
infected with HIV. Ultimately, there is a need to have al-
gorithms that specify which patients infected with HIV 
will get screened for adrenal function as the features of  
hypocortisolism are non-specific and may not be recog-
nized in HIV because they are masked by the features of  
other opportunistic infections.
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